ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $277,620 | +23.4% | 8,400 | +71.4% | 0.00% | +50.0% |
| Q1 2022 | $225,000 | -30.8% | 4,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $325,000 | -18.8% | 4,900 | -23.4% | 0.00% | -50.0% |
| Q3 2021 | $400,000 | -51.7% | 6,400 | -36.0% | 0.00% | -50.0% |
| Q2 2021 | $828,000 | +22.5% | 10,000 | -2.0% | 0.01% | +14.3% |
| Q1 2021 | $676,000 | -16.9% | 10,200 | -3.8% | 0.01% | -22.2% |
| Q4 2020 | $813,000 | +38.7% | 10,600 | -22.1% | 0.01% | +28.6% |
| Q3 2020 | $586,000 | -27.8% | 13,600 | -27.7% | 0.01% | -30.0% |
| Q2 2020 | $812,000 | +168.9% | 18,800 | +79.0% | 0.01% | +150.0% |
| Q1 2020 | $302,000 | -20.7% | 10,500 | +75.0% | 0.00% | 0.0% |
| Q4 2019 | $381,000 | -37.5% | 6,000 | -73.9% | 0.00% | -42.9% |
| Q2 2019 | $610,000 | +56.0% | 23,000 | +8.0% | 0.01% | +40.0% |
| Q1 2019 | $391,000 | -6.5% | 21,300 | -2.3% | 0.01% | 0.0% |
| Q3 2018 | $418,000 | – | 21,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |